Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

787
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
787
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Nursing Ethical Principles II01:27

Nursing Ethical Principles II

2.3K
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
2.3K
Cancer Therapies02:49

Cancer Therapies

10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypoalbuminemia as a Predictive Biomarker of Dyspnea Response to Dexamethasone and Placebo in Patients With Cancer: Secondary Analysis of the ABCD Randomized Clinical Trial.

JCO precision oncology·2026
Same author

Tuberculosis Infection: Diagnosis and Management.

Cold Spring Harbor perspectives in medicine·2026
Same author

Prediction of 48-h Intensive Care Unit Mortality in Hospitalized Cancer Patients: Performance of the EPIC Deterioration Index and Sequential Organ Failure Assessment Score.

Journal of intensive care medicine·2026
Same author

Generative Artificial Intelligence Use in the Peer Review Process.

Journal of pain and symptom management·2026
Same author

Effect of Specialist Palliative Care on Acute Healthcare in Stage IV Cancer: Prior Event Rate Ratio.

Journal of pain and symptom management·2026
Same author

Predictive biomarkers of placebo response in patients with cancer: an exploratory analysis of the ABCD randomized clinical trial.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026

Related Experiment Video

Updated: Feb 18, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

11.1K

Perception of Curability Among Advanced Cancer Patients: An International Collaborative Study.

Sriram Yennurajalingam1, Luis Fernando Rodrigues2, Omar Shamieh3

  • 1Department of Palliative Care, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Barretos, Brazil syennu@mdanderson.org.

The Oncologist
|November 22, 2017
PubMed
Summary

Fifty-five percent of advanced cancer patients inaccurately believe their illness is curable. This misperception varies by gender, education, performance status, employment, and country, highlighting a need for better communication.

Keywords:
CancerDecision‐making preferencePalliative carePerception of curabilityPrognostic awareness

Related Experiment Videos

Last Updated: Feb 18, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

11.1K

Area of Science:

  • Oncology
  • Palliative Care
  • Health Psychology

Background:

  • Limited global data exists on advanced cancer patients' understanding of their illness and perception of cure.
  • Assessing illness perception is crucial for effective end-of-life care and patient-centered communication.

Purpose of the Study:

  • To determine the frequency of inaccurate perception of curability among advanced cancer patients receiving palliative care worldwide.
  • To identify factors associated with this misperception across diverse global populations.

Main Methods:

  • Secondary analysis of a global study involving advanced cancer patients receiving palliative care.
  • Utilized Patient Illness Understanding survey and Control Preference Scale data.
  • Employed descriptive statistics and multivariate logistic regression for analysis.

Main Results:

  • 55% of patients inaccurately perceived their advanced cancer as curable.
  • Accurate perception was linked to female gender, higher education, unemployment, and specific countries (France, South Africa).
  • Inaccurate perception correlated with better performance status and origin from Philippines, Jordan, Brazil, and India.

Conclusions:

  • A significant proportion of advanced cancer patients hold inaccurate beliefs about their curability.
  • Perception of curability is influenced by demographic, socioeconomic, and geographic factors.
  • Developing strategies to improve patient-physician communication is essential to address this misperception and enhance care outcomes.